Free Trial
OTCMKTS:GBLX

GB Sciences (GBLX) Stock Price, News & Analysis

GB Sciences logo
$0.0003 0.00 (-25.00%)
As of 03/31/2025 11:34 AM Eastern

About GB Sciences Stock (OTCMKTS:GBLX)

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.0001
$0.0135
Volume
1,500 shs
Average Volume
111,983 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GB Sciences, Inc., a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.

Remove Ads
Receive GBLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GB Sciences and its competitors with MarketBeat's FREE daily newsletter.

GBLX Stock News Headlines

GB Sciences Reports Delay in Quarterly Filing
GB Sciences, Inc. (GBLX) stock forecast and price target
New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
GB Sciences Inc (GBLX)
See More Headlines

GBLX Stock Analysis - Frequently Asked Questions

GB Sciences' stock was trading at $0.0040 at the beginning of the year. Since then, GBLX shares have decreased by 92.5% and is now trading at $0.0003.
View the best growth stocks for 2025 here
.

GB Sciences, Inc. (OTCMKTS:GBLX) issued its quarterly earnings results on Monday, November, 14th. The company reported ($0.04) earnings per share for the quarter.

Shares of GBLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GB Sciences investors own include Canopy Growth (CGC), 22nd Century Group (XXII), NVIDIA (NVDA), Unrivaled Brands (TRTC), Trees (CANN), Aurora Cannabis (ACB) and Meta Platforms (META).

Company Calendar

Last Earnings
11/14/2016
Today
4/01/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Cannabis
Current Symbol
OTCMKTS:GBLX
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:GBLX) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners